Doc for acute exacerbation of asthma in stable asthma asthma(not status asthmaticus)
SABA or LABA
In the management of acute exacerbation of asthma in stable asthma (not status asthmaticus), short-acting beta-agonists (SABAs) are typically the first-line treatment.
SABAs such as albuterol, levalbuterol, and terbutaline are effective bronchodilators that work quickly to relieve symptoms such as wheezing, coughing, and shortness of breath. They can be administered via inhaler or nebulizer.
For patients with more severe or persistent symptoms, the addition of an inhaled corticosteroid (ICS) may be beneficial. ICSs, such as fluticasone or budesonide, reduce inflammation in the airways and help to prevent future exacerbations.
Long-acting beta-agonists (LABAs) such as salmeterol or formoterol may also be used in combination with an ICS in patients with more severe or persistent asthma, but they are not recommended as first-line therapy for acute exacerbations.
It is important to note that in the case of an acute exacerbation, patients should seek medical attention from a healthcare professional. They can evaluate the severity of the exacerbation and provide appropriate treatment.